SCHEDULE 13G/A: SUNCORPORATION Discloses Significant 43.7% Stake in Cellebrite DI Ltd.

SUNCORPORATION has reported a beneficial ownership of 43.7% of Cellebrite DI Ltd.'s ordinary shares, totaling 102,576,122 shares, as of December 31, 2024.

Summary

• SUNCORPORATION, a Japanese entity, beneficially owns 102,576,122 ordinary shares of Cellebrite DI Ltd.
• This ownership represents 43.7% of Cellebrite DI Ltd.'s outstanding ordinary shares.
• SUNCORPORATION holds sole voting power and sole dispositive power over all 102,576,122 shares.
• The filing is an Amendment No. 3 to a Schedule 13G, indicating a previous disclosure of ownership.
• Cellebrite DI Ltd.'s principal executive offices are located at 94 Shlomo Shmelzer Road, Petah Tikva, Israel.

Sentiment

Score: 7

Explanation: The filing indicates a substantial and stable ownership stake by SUNCORPORATION, a parent holding company, in Cellebrite DI Ltd., suggesting strong strategic alignment and commitment.

Positives

• SUNCORPORATION's substantial 43.7% ownership stake in Cellebrite DI Ltd. demonstrates a significant commitment and potential strategic alignment.
• The sole voting and dispositive power over these shares provides SUNCORPORATION with considerable influence over Cellebrite's future direction, potentially indicating stability.

Negatives

• No specific negative information was disclosed in this Schedule 13G filing.

Risks

• No specific risks were detailed in this Schedule 13G filing, as it primarily concerns beneficial ownership disclosure.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding future outlook.

Management Comments

• This Schedule 13G filing does not contain direct management comments from Cellebrite DI Ltd. or SUNCORPORATION beyond the certification statement by Yoshmi Kimura, Representative and Executive Managing Director of SUNCORPORATION.

Industry Context

This Schedule 13G filing primarily concerns a change in beneficial ownership disclosure and does not provide specific industry context or trends.

Comparison to Industry Standards

• This Schedule 13G filing is a regulatory disclosure of beneficial ownership and does not include comparisons to industry standards or specific comparable companies/projects.

Stakeholder Impact

• Shareholders of Cellebrite DI Ltd. gain transparency regarding the significant and stable ownership stake held by SUNCORPORATION, which could imply long-term strategic stability and alignment.

Next Steps

• The document does not specify future actions or milestones beyond the regulatory filing requirement.

Key Dates

Recommendation

Keywords

Cellebrite DI Ltd., SUNCORPORATION, Schedule 13G, Beneficial Ownership, Ordinary Shares, Shareholding, SEC Filing, Investment, Corporate Governance